Hims & Hers Health, Inc. (NYSE:HIMS) COO Melissa Baird Sells 9,133 Shares

Hims & Hers Health, Inc. (NYSE:HIMS) COO Melissa Baird sold 9,133 shares of Hims & Hers Health stock in a transaction on Tuesday, September 5th. The shares were sold at an average price of $6.80, for a total transaction of $62,104.40. Following the transaction, the chief operating officer now owns 408,485 shares in the company, valued at approximately $2,777,698. The transaction was disclosed in a legal filing with the SEC, which is available at this link.

Melissa Baird also recently made the following trade(s):

• On Friday, September 1st, Melissa Baird sold 9,133 shares of Hims & Hers Health stock. The shares were sold at an average price of $6.87, for a total transaction of $62,743.71.
• On Monday, August 7th, Melissa Baird sold 9,133 shares of Hims & Hers Health stock. The shares were sold at an average price of $8.00, for a total transaction of $73,064.00.
• On Thursday, August 3rd, Melissa Baird sold 9,133 shares of Hims & Hers Health stock. The shares were sold at an average price of $8.26, for a total transaction of $75,438.58.
• On Wednesday, July 5th, Melissa Baird sold 9,133 shares of Hims & Hers Health stock. The shares were sold at an average price of $8.88, for a total transaction of $81,101.04.
• On Monday, July 3rd, Melissa Baird sold 9,133 shares of Hims & Hers Health stock. The stock was sold at an average price of $9.19, for a total transaction of $83,932.27.

Hims & Hers Health Stock Up 0.4 %

Hims & Hers Health stock opened at $6.92 on Thursday. The firm has a 50-day moving average price of $7.91 and a two-hundred day moving average price of $9.18. The firm has a market capitalization of $1.46 billion, a price-to-earnings ratio of -31.43 and a beta of 0.53. Hims & Hers Health, Inc. has a 52-week low of $4.01 and a 52-week high of $12.34.

Hims & Hers Health (NYSE:HIMS) last posted its earnings results on Monday, August 7th. The company reported ($0.03) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.06) by $0.03. The firm had revenue of $207.91 million during the quarter, compared to analyst estimates of $204.95 million. Hims & Hers Health had a negative net margin of 6.61% and a negative return on equity of 14.97%. Hims & Hers Health’s revenue was up 83.1% on a year-over-year basis. During the same period in the previous year, the business posted ($0.10) EPS. Research analysts expect that Hims & Hers Health, Inc. will post -0.15 earnings per share for the current year.

Wall Street Analysts Forecast Growth

Several equities research analysts recently issued reports on HIMS shares. TD Cowen started coverage on shares of Hims & Hers Health in a research note on Friday, July 28th. They set an “outperform” rating and a $11.00 price target on the stock. Piper Sandler dropped their price target on shares of Hims & Hers Health from $11.00 to $10.00 in a research note on Tuesday, August 8th. Truist Financial dropped their price target on shares of Hims & Hers Health from $12.00 to $10.00 and set a “hold” rating on the stock in a research note on Wednesday, August 9th. Credit Suisse Group reaffirmed an “outperform” rating and set a $14.00 price target on shares of Hims & Hers Health in a research note on Tuesday, August 8th. Finally, Tigress Financial lifted their price target on shares of Hims & Hers Health from $12.00 to $14.00 in a research note on Thursday, June 15th. Three investment analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $11.75.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently bought and sold shares of HIMS. Virginia Retirement Systems ET AL acquired a new stake in shares of Hims & Hers Health in the 2nd quarter worth approximately $203,000. California State Teachers Retirement System boosted its holdings in shares of Hims & Hers Health by 3.3% in the second quarter. California State Teachers Retirement System now owns 155,105 shares of the company’s stock valued at $1,458,000 after acquiring an additional 4,899 shares in the last quarter. Coppell Advisory Solutions LLC bought a new position in shares of Hims & Hers Health in the second quarter valued at approximately $47,000. Nuveen Asset Management LLC boosted its holdings in shares of Hims & Hers Health by 67.8% in the second quarter. Nuveen Asset Management LLC now owns 2,893,215 shares of the company’s stock valued at $27,196,000 after acquiring an additional 1,168,534 shares in the last quarter. Finally, GTS Securities LLC bought a new position in shares of Hims & Hers Health in the second quarter valued at approximately $157,000. 61.45% of the stock is owned by institutional investors and hedge funds.

Hims & Hers Health Company Profile

Hims & Hers Health, Inc operates a telehealth platform that connects consumers to licensed healthcare professionals. The company offers a range of health and wellness products and services available to purchase on its websites and mobile application directly by customers. It also provides prescription medication on a recurring basis and ongoing care from healthcare providers; and over-the-counter drug and device products, cosmetics, and supplement products, primarily focusing on wellness, sexual health and wellness, skincare, and hair care.